New drug NRS 033 tested in healthy people for first time
NCT ID NCT05724797
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single dose of the experimental drug NRS 033 in 24 healthy adults aged 18 to 55. The main goal was to check safety and how the drug moves through the body. No treatment was given for any disease, so this study does not offer any direct health benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Frontage Clinical Research Center
Secaucus, New Jersey, 07094, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A 10-second sprint may reveal who gains the most muscle from weight training
- Can a needle and a zap boost athletic performance? a trial puts five nerve-stimulation patterns to the test.
- Can an inhaled powder stop lung scarring? a safety trial begins
- Avocado at breakfast: a secret weapon for blood sugar and fullness?
- Could a gentle buzz behind the ears tune your heart's rhythm?
- Training Non-Radiology staff to take X-Rays: a feasibility test